On September 20-24, 2011, the US-Algeria Business Council and the Embassy of Algeria in Washington, DC hosted the 2011 US-Algeria Innovative Pharmaceutical Study Tour to Boston, Massachusetts and Washington, DC.  The delegation from Algeria was lead by H.E. Minister Djamel Ould Abbes and was composed of thirty officials from the Ministry of Health, the Ministry of Labor, the Ministry of Higher Education, public and private pharmaceutical companies, research centers and regulatory agencies.This unprecedented study tour was composed of technical visits to laboratories and universities, including the prestigious Northeastern University of Boston, MA, and meetings with leading decision makers from international pharmaceutical companies and public institutions and regulatory agencies. 

One of the highlights of the four day mission was the meeting between US Secretary of Health, the Honorable Kathleen Sebelius and H.E. Minister Djamel Ould Abbes at the US Department of Health & Human Services.  This important meeting was the first of its kind between an active Minister of Health and a US Secretary of Health and Human Services.  The 2011 Innovative Pharmaceutical Study Tour has ushered in a transparent and productive dialogue in the key public and private decision makers in the Algerian pharmaceutical market. 

The 2011 US-Algeria Pharmaceutical Study Tour was the follow-up activity from the US-Algeria pharmaceutical initiative recently launched in Algeria. During the 2011 US-Algeria Health Forum & Expo on June 8-9, 2011 in Algiers, Algeria, key players from the international pharmaceutical industry joined together to invite H.E. Minister Djamel Ould Abbes, the Algerian Minister of Health, to come to the United States with key officials for a technical study tour.

___________________________________________________

The US-Algeria Business Council and the Embassy of Algeria in Washington, DC, hosted the 2011 US-Algeria Health Forum & Expo under the High Patronage of H.E. Minister Djamel Ould Abbes, the Algerian Minister of Health, on June 8-9, 2011, in Algiers, Algeria. The medical sector is one of the most important sectors of trade between the United States and Algeria and US pharmaceutical companies were some of the pioneers to invest and operate in Algeria in the years after Independence. Building on this strong legacy, numerous US medical and pharmaceutical firms are eagerly seeking opportunities in Algeria.

On June 8 and 9 in Algiers, Algeria the key players from the US and Algerian private and public sector assembled to discuss new avenues of partnership, and collaboration. Algerian providers, officials, pharmaceutical companies, media figures and key decision makers gathered to meet their US counterparts in this exclusive forum. Expo space featured the latest technology in the pharmaceutical medical field and provided a hands-on experience with medical equipment suppliers.

 

2011 US-ALGERIA HEALTH FORUM & EXPO
AGENDA & PRESENTATIONS

Wednesday, June 8, 2011

9:00am-9:45am Welcome & Keynote Address

• Dr. Ismael Chikhoune, President and CEO, US-Algeria Business Council
• Mr. William Jordan, US Deputy Chief of Mission, US Embassy in Algeria
• H.E. Minister Mohamed Benmeradi, Minister of Industry, Investment & SMEs of Algeria
• H.E. Minister Rachid Harouabia, Minister of High Education and Scientific Research of Algeria
• H.E. Minister Djamel Ould Abbes, Minister of Health of Algeria

9:45am-11:00am Global Trends in the Biopharmaceutical Sector

MODERATOR - Mr. Omar Ehsan, General Manager, IMS Africa

• Mr. John Steele, Eli Lilly and Company
• PRESENTATION Mr. Ashraf Allam, Vice President of Middle East and Africa, Amgen
• PRESENTATION Mr. Omar Ehsan, General Manager, IMS Africa

11:00am-11:20am Exhibitors welcome H.E. Minister Djamel Ould Abbes to visit the exhibits

11:30pm-12:15pm Pharmaceutical & Biopharmaceutical Vision & Roadmap for Algeria

MODERATOR - Mr. Omar Ehsan, General Manager, IMS Africa

• PRESENTATION Industry Perspectives on Policy Challenges and Opportunities in Algeria- a New Partnership Approach - Mr. Jeffrey P. Kemprecos, Executive Director, Public Policy and Corporate Responsibility, MSD Eastern Europe, Middle East and Africa,
• PRESENTATION Vision and Roadmap Biopharmaceutical Investment Project: Algeria 2020 - Mr. Parham Gohari, Senior Manager Middle East Strategy, Deloitte
• PRESENTATION The Pharmaceutical Industry & the National Agenda in Medicine - Dr. Hamou Hafed, Director of Pharmacy, Ministry of Health of Algeria

12:30pm-1:30pm Networking Luncheon

2:00pm-2:45pm Biotechnology & its Future in Algeria

MODERATOR - Mr. Omar Ehsan, General Manager, IMS Africa

• PRESENTATION Mr. Ashraf Allam, Regional Managing Director for the Middle East and Africa, Amgen

2:45pm-4:30pm Trends in Attracting Manufacturing Investment & Algeria’s Vision

MODERATOR - Mr. Omar Ehsan, General Manager, IMS Africa

• PRESENTATION Mr. Samir Larak, General Manager Algeria, GlaxoSmithKline
• PRESENTATION Mr. Boumediene Derkaoui, President & CEO of Saidal  

4:30pm-5:30pm Exhibitors welcome the audience to visit the exhibits

 

Thursday, June 9, 2011

9:00am-9:45am Welcome

• Dr. Ismael Chikhoune, President and CEO, US-Algeria Business Council

9:45am-10:45am Trends in Diagnostics, Patient Care, and Provider Training

MODERATOR - Mr. Omar Ehsan, General Manager, IMS Africa

• PRESENTATION Mr. Karim Harchaoui, Managing Director, GE Healthcare Algeria
• PRESENTATION Innovation & Sustainability - Mr. Klaus Brill, Bayer
• PRESENTATION Mr. Brian Chance, Director, Healthcare Strategic Initiatives, Raytheon Professional Services

10:45am-12:00pm Trends in Clinical Trial Research & Opportunities in Algeria

MODERATOR - Mr. Omar Ehsan, General Manager, IMS Africa

• PRESENTATION Dr. Cellia Habita, President & CEO, Arianne Corporation
• PRESENTATION Medical R&D: Creating Algeria’s Future-Mr. Guy van den Hoven, Medical R&D Director CEEMEA, Astra Zeneca
• PRESENTATION Status of Clinical Trials in Algeria- Mr. Mohamed l’Hadj, Deputy Director of Pharmacy, Ministry of Health of Algeria

12:00pm-1:30pm Chairman’s Luncheon hosted by Raytheon

2:00pm-3:00pm Trends in Global Anti-Counterfeiting

MODERATOR - Mr. Omar Ehsan, General Manager, IMS Africa

• The counterfeiting of medications: a scourge to patient health - Mr. Pierre Souverain, Global Security, EMEA, Pfizer
• PRESENTATION Algerian Strategy to Combat Pharmaceutical Counterfeiting - Pr. Mohamed Mansouri, Director of National Quality Control Laboratory of Algeria

3:00pm-4:15pm Developments in Global Regulatory Harmonization, Increasing Access to Innovative Therapy & Sharing and Participating in Algeria’s Vision

MODERATOR - Mr. Omar Ehsan, General Manager, IMS Africa

• PRESENTATION Access to innovative therapies - Dr. Khalil Kadaoui, Head of Market Access, Novartis Algeria
• PRESENTATION Global Trends in Regulatory Harmonization- Dr. Nicholas Cappuccino, PhD, CEO, Pharmaceutical Intellectual Resource Services LLC

2011 US-ALGERIA HEALTH FORUM & EXPO
THANK YOU TO OUR SPONSORS

         

                                   

   
                         

                                        

___________________________________________________